Advertisement
News
Advertisement

VC-backed Vedanta to target cancer via 'good' bacteria

Thu, 12/23/2010 - 10:33am
Mass High Tech: The Journal of New England Technology

In the past five years, scientists have discovered that microbes living in your gut may be responsible for a great many things that contribute to your well-being – from your mood, to your body’s response to sickness.

Now, venture capital firm PureTech Ventures is launching a new company, called Vedanta Biosciences. Incubated in PureTech’s Boston offices, Vedanta aims to commercialize research newly published today in the academic journal Science that indicates beneficial, gut-dwelling bacteria may also be useful for combating allergies and inflammatory bowel disease (IBD).

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading